Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression.

PeerJ · 2013 · PMC3840466 · PMID 24282673

Europe PMC DOI

hedged sentences

0.0579

closest p · 1.2× alpha

0.1089

boldest claim

The sentences

a strong trendP = 0.0579so close (0.05 < p ≤ 0.1)

The PTZ-induced increase of Fos mRNA expression in CBDV responders was suppressed in the neocortex ( P = 0.0274) and the prefrontal cortex ( P = 0.0337), and there was a strong trend towards a decrease in the hippocampus ( P = 0.0579; Fig. 5A ).

also in 5,725 other papers

showed a trendP = 0.1089not close (p > 0.1)

Effects of PTZ treatment on mRNA expression of epilepsy-related genes in the hippocampus, neocortex and prefrontal cortex PTZ treatment significantly upregulated Fos mRNA expression in neocortex ( P = 0.0001) and prefrontal cortex ( P = 0.0003; Table 1 ) whilst hippocampal Fos mRNA expression only showed a trend to increase ( P = 0.1089).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.